Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study
2005

Nuclear Factor-kappaB in Prostate Cancer

Sample size: 75 publication Evidence: moderate

Author Information

Author(s): Lessard L, Bégin L R, Gleave M E, Mes-Masson A-M, Saad F

Primary Institution: Centre de recherche du CHUM, and Institut du cancer de Montréal

Hypothesis

What is the status of NF-κB transcription factors in prostate cancer tissues?

Conclusion

The study found that different NF-κB pathways may be activated in prostate cancer progression.

Supporting Evidence

  • All NF-κB subunits were expressed in prostate tissues.
  • Nuclear RelB expression increased significantly with Gleason scores.
  • Nuclear localisation of RelA and p50 was less frequently detected than other subunit combinations.

Takeaway

This study looked at how certain proteins behave in prostate cancer cells, finding that many of them are active in the cancer and might help it grow.

Methodology

The study used tissue microarrays and immunohistochemical staining to analyze NF-κB subunits in prostate cancer specimens.

Limitations

The study did not assess the presence of specific heterodimers in prostate cancer specimens.

Participant Demographics

Caucasian men with prostate cancer.

Statistical Information

P-Value

0.018

Statistical Significance

p=0.018

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602796

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication